Skip to main content
SpringerLink
Log in

Durable complete remission after single agent decitabine in AML relapsing in extramedullary sites after allo-SCT

  • Letter to the Editor
  • Published:
Bone Marrow Transplantation Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1
Figure 2

References

  1. Bolanos-Meade J, Smith BD, Gore SD, McDevitt MA, Luznik L, Fuchs EJ et al. 5-Azacytidine as salvage treatment in relapsed myeloid tumors after allogeneic bone marrow transplantation. Biol Blood and Marrow Transplant 2011; 17: 754–758.

    Article  CAS  Google Scholar 

  2. Issa JP, Garcia-Manero G, Giles FJ, Mannari R, Thomas D, Faderi S et al. Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2′-deoxycytidine (decitabine) in hematopoietic malignancies. Blood 2004; 103: 1635–1640.

    Article  CAS  PubMed  Google Scholar 

  3. Graef T, Kuendgen A, Fenk R, Zohren F, Haas R, Kobbe G . Successful treatment of relapsed AML after allogeneic stem cell transplantation with azacitidine. Leuk Res 2007; 31: 257–259.

    Article  CAS  PubMed  Google Scholar 

  4. Jabbour E, Giralt S, Kantarjian H, Garcia-Manero G, Jagasia M, Kebriaei P et al. Low-dose azacitidine after allogeneic stem cell transplantation for acute leukemia. Cancer 2009; 115: 1899–1905.

    Article  CAS  PubMed  Google Scholar 

  5. Guieze R, Jouinot A, Itzykson R, Thepot S, Guillaurne T, Coiteux V et al. Azacytidine (AZA) in relapsed MDS and AML after allogeneic stem cell transplantation (allo-HSCT): results of the French ATU Program. Blood 2010; 116 (ASH 2010 Annual Meeting Abstracts) 1293.

    Google Scholar 

  6. Koc Y, Miller KB, Schenkein DP, Daoust P, Sprague K, Berkman E . Extramedullary tumors of myeloid blasts in adults as a pattern of relapse following allogeneic bone marrow transplantation. Cancer 1999; 85: 608–615.

    Article  CAS  PubMed  Google Scholar 

  7. Clark WB, Strickland SA, Barrett AJ, Savani B . Extramedullary relapses after allogeneic stem cell transplantation for acute myeloid leukemia and myelodysplastic syndrome. Haematologica 2010; 95: 860–862.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Kolb HJ . Graft-versus-leukemia effects of transplantation and donor lymphocytes. Blood 2008; 112: 4371–4383.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Maryland Medical Center, Marlene and Stewart Greenebaum Cancer Center, Baltimore, MD, USA

    S N Singh, Q Cao, I Gojo, A P Rapoport & G Akpek

Authors
  1. S N Singh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Q Cao
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. I Gojo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A P Rapoport
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. G Akpek
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to G Akpek.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Singh, S., Cao, Q., Gojo, I. et al. Durable complete remission after single agent decitabine in AML relapsing in extramedullary sites after allo-SCT. Bone Marrow Transplant 47, 1008–1009 (2012). https://doi.org/10.1038/bmt.2011.210

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2011.210

  • Springer Nature Limited

This article is cited by

Search

Navigation